ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Discover Why Ashwagandha Can Be Used for Stress and Anxiety

How Can You Benefit From Vitamin B12?

Calorie restriction promotes longevity through effects on mitochondrial network

Lower magnesium levels linked with increased mortality risk during up to 40 years of follow-up

Higher resveratrol dose linked to lower glucose levels in type 2 diabetics

What Is Bitter Orange?

Black Tea Is Great for Your Gut

Drug can dramatically reduce weight of people with obesity

Tryptophan's Possible Effects for Your Health

New Finding: Broccoli Helps Heal Leaky Gut

 
Print Page
Email Article

New Findings Show Reminyl® Slows Cognitive Decline By 60 % in Alzheimer's

  [ 167 votes ]   [ Discuss This Article ]
www.ProHealth.com • May 23, 2003


Treatment with Reminyl® (galantamine hydrobromide) may slow the progression of mild to moderate Alzheimer's disease by 50 to 60 percent when used continuously for 48 months, according to a new study presented at the 156th Annual Meeting of the American Psychiatric Association.

The data showed that more than 12 percent of patients did not deteriorate at all. While the remaining patients showed varying degrees of deterioration, the investigators concluded that it was less than would be expected in an untreated Alzheimer's disease population. With 240 patients evaluated over the full 48 months, this is the largest long-term study of its kind.

"This study provides additional evidence that long-term therapy with Reminyl can have long-term benefits, by delaying the natural rate of decline," said Luc Truyen, M.D., Ph.D., Senior Director, Clinical Development, CNS, Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), and a study co-author. "For participants in this four-year study, cognitive decline was significantly delayed compared to the natural rate of decline in untreated patients."

Dr. Truyen noted that Alzheimer's disease typically progresses over the course of 10 years, and that the data showed continuous benefit from Reminyl during the entire four-year period.

The study consisted of open-label extensions of two double-blind, placebo- controlled trials. Patients received 24 to 32 mg of Reminyl daily during the initial three to six month blinded portions of the research; during the open-label extensions, the 240 patients received 24 mg of Reminyl every day.

The research focused on patients' cognitive performance, which includes the ability to think, reason and learn. Among participants receiving Reminyl, scores on the cognitive portion of the Alzheimer's Disease Assessment Scale (ADAS-cog) deteriorated 12.8 points. This compares to an expected decline of 24 to 36 points for untreated patients, based on the Stern equation, a standard measurement of cognitive decline in people with Alzheimer's disease.

Reminyl is thought to inhibit an enzyme that breaks down acetylcholine -- a neurotransmitter in the brain that plays a key role in memory and learning. In addition, it is believed that Reminyl modulates the brain's nicotinic receptors, to which acetylcholine binds. The clinical significance of these mechanisms is unknown.

"These findings should give Alzheimer's disease patients and caregivers hope that the progression of symptoms in this disabling disorder can be slowed for many sufferers, an important consideration as families and patients focus on getting the most out of the time they have," said Gordon Wilcock, Professor of Care of The Elderly, University of Bristol, UK, and a study investigator.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Mitochondria Ignite™ with NT Factor® Ultra ATP+, Double Strength


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Restoring Gut Health: How to Create a Firewall Against Toxins Entering the Gut Wall Restoring Gut Health: How to Create a Firewall Against Toxins Entering the Gut Wall
Strengthen Cell Function with Energy-Boosting Niagen Strengthen Cell Function with Energy-Boosting Niagen
Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
The Super Antioxidant for Brain, Joint and Heart Health The Super Antioxidant for Brain, Joint and Heart Health
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map